Strumento inattivo

Azioni Epirus Biopharmaceuticals Inc Other OTC

Azioni

Durata

Periodo

Stile

Transcript : EPIRUS Biopharmaceuticals, Inc., Q4 2015 Earnings Call, Mar 15, 2016	15/03/16
Transcript : EPIRUS Biopharmaceuticals, Inc., Q3 2015 Earnings Call, Nov 16, 2015	16/11/15
Transcript : EPIRUS Biopharmaceuticals, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-11-2015 01:20 PM	11/08/15
Transcript : EPIRUS Biopharmaceuticals, Inc., Zalicus Inc. - M&A Call	16/04/14

Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	09/10/18
Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	31/01/18
Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	19/01/18
Praxis Precision Medicines, Inc. agreed to acquire Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q) for $1 million.	18/01/18
Notice of Intent of Asset Sale Filed by EPIRUS Biopharmaceuticals, Inc.	11/12/17

EPIRUS Biopharmaceuticals, Inc. è in bancarotta.

Settore

	Variaz. 1 gen.	Capi.
MODERNA, INC.	+26,28%	42,68 Mrd
IQVIA HOLDINGS INC.	-3,99%	42,4 Mrd
LONZA GROUP AG	+45,32%	40,04 Mrd
CELLTRION, INC.	-6,20%	28,31 Mrd
ICON PUBLIC LIMITED COMPANY	+6,36%	24,94 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-21,47%	18,96 Mrd
MEDPACE HOLDINGS, INC.	+27,58%	12,3 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-2,75%	11,95 Mrd
BIO-TECHNE CORPORATION	-2,02%	11,55 Mrd